February 27, 2026

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: A Potential 233% Upside in the Healthcare Sector

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company, is capturing investor attention with its substantial potential upside of 233.33%, making it a noteworthy candidate for those interested in the healthcare..

HealthStream, Inc. (HSTM) Stock Report: Exploring a 42.99% Potential Upside

HealthStream, Inc. (HSTM), a key player in the healthcare sector specializing in health information services, offers a compelling investment opportunity with an estimated potential upside of 42.99%. As of the..

Stoke Therapeutics (STOK) Investor Outlook: A Promising Biotech with 17.3% Upside Potential

Stoke Therapeutics, Inc. (STOK), a burgeoning name in the biotechnology sector, is captivating investor interest with its promising pipeline of genetic treatments and a notable potential upside of 17.3%. The..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Unpacking the 82% Potential Upside

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a frontrunner in the biotechnology sector, is making waves with its ambitious aim to revolutionize treatment methodologies for diseases with unmet medical needs, particularly Duchenne..

RxSight, Inc. (RXST) Investor Outlook: Exploring a 28% Potential Upside in the Medical Devices Sector

RxSight, Inc. (RXST), a promising player in the medical technology arena, presents a unique opportunity for investors seeking exposure to the healthcare sector, specifically in the innovative medical devices space...

CareDx, Inc. (CDNA) Stock Analysis: 27.52% Potential Upside in the Healthcare Diagnostics Sector

CareDx, Inc. (CDNA), a prominent player in the healthcare diagnostics and research sector, has caught the eye of investors with its robust growth prospects and a noteworthy potential upside of..

InnovAge Holding Corp. (INNV) Stock Analysis: Evaluating the -24.73% Potential Downside Amid Healthcare Growth

InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, specializes in providing comprehensive medical and ancillary services tailored for seniors, ensuring they can live independently while receiving..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring a 21% Potential Upside in the Healthcare Sector

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a notable player in the healthcare sector, has captured investor attention with its robust pipeline of pain management medications and promising financial metrics. With a..

Talkspace, Inc. (TALK) Stock Analysis: Exploring a 35% Upside Potential and Strong Buy Ratings

For investors looking to navigate the dynamic field of healthcare technology, Talkspace, Inc. (NASDAQ: TALK) presents a compelling opportunity. Positioned within the burgeoning sector of virtual behavioral healthcare, Talkspace offers..

OrthoPediatrics Corp. (KIDS) Stock Analysis: A 34.91% Potential Upside Amid Strong Buy Ratings

OrthoPediatrics Corp. (NASDAQ: KIDS), a pioneering player in the healthcare sector focused on pediatric orthopedic solutions, stands at a pivotal juncture for investors with a potential upside of 34.91%. This..

Owens & Minor, Inc. (OMI) Stock Analysis: Is the 94% Potential Upside Worth the Risk?

Owens & Minor, Inc. (NYSE: OMI), a notable player in the healthcare sector specializing in medical distribution, presents a compelling narrative for investors with its standout potential upside of 94.29%...

uniQure N.V. (QURE) Stock Analysis: A Potential 210% Upside in the Biotechnology Sector

For investors with an eye on the biotechnology sector, uniQure N.V. (QURE) is a fascinating opportunity. Headquartered in Amsterdam, this Dutch company is a prominent player in the healthcare industry,..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: A 41.98% Potential Upside Beckons Investors

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a Massachusetts-based clinical-stage pharmaceutical company, is causing a stir in the healthcare sector with its focus on cutting-edge treatments for neurodegenerative diseases and endocrine conditions...

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Assessing a Potential 14% Upside in the Biotechnology Sector

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) presents a compelling investment opportunity in the biotechnology sector, with a potential upside of 14.37%, according to current analyst ratings. With a market capitalization..

AxoGen, Inc. (AXGN) Stock Analysis: Strong Buy Ratings Signal a 22.88% Upside Potential

AxoGen, Inc. (NASDAQ: AXGN), a key player in the healthcare sector specializing in medical devices for peripheral nerve regeneration and repair, has been drawing significant attention from investors. With a..

AnaptysBio, Inc. (ANAB) Stock Analysis: A Biotech with 21% Potential Upside

AnaptysBio, Inc. (ANAB) has recently emerged as a compelling opportunity for investors in the biotech sector, particularly those with an eye for innovative developments in immunology therapeutics. Based in San..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring a 61.57% Potential Upside in Precision Medicine

Relay Therapeutics, Inc. (RLAY) is capturing investor attention with its position as a clinical-stage precision medicines company in the biotechnology industry. With a market capitalization of $1.59 billion, this Cambridge,..

Simulations Plus, Inc. (SLP) Stock Analysis: A 104% Potential Upside Despite Recent Headwinds

Simulations Plus, Inc. (NASDAQ: SLP) stands at an intriguing crossroads for investors, offering a blend of advanced technological solutions in health information services with significant potential upside. Despite recent challenges,..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Exploring a 37.94% Upside Potential in Biotech

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a dynamic player in the biotechnology sector, is catching the eye of many investors due to its ambitious pursuit of innovative cancer treatments and a..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Uncertain Waters with a Potential Downside

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, operates an extensive network of general acute care hospitals across the United States. Despite its substantial presence..

Search

Funds

February 27, 2026

Search

Funds

February 27, 2026

FTSE 100

Funds